Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10389)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Janicko M, Drazilova S, Pella D, Fedacko J, Jarcuska P. Pleiotropic effects of statins in the diseases of the liver. World J Gastroenterol 2016; 22(27): 6201-6213 [PMID: 27468210 DOI: 10.3748/wjg.v22.i27.6201] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i27/6201.htm |
| Number | Citing Articles |
| 1 |
Sean Sileno, Razvan M. Chirila, Dana M. Harris. Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians. Romanian Journal of Internal Medicine 2020; 58(4): 181 doi: 10.2478/rjim-2020-0018
|
| 2 |
Andrea Dalbeni, Rosanna Villani, Michele Bevilacqua, Federica Sacco, Diego Faccincani, Filippo Cattazzo, Francesco Cavallone, Anna Mantovani, Vittoria Ceruti, Donatella Ieluzzi, Veronica Paon, Alessandro Mantovani, Gaetano Serviddio, David Sacerdoti. Effects of direct‐acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real‐life Italian experience. Journal of Digestive Diseases 2022; 23(5-6): 324 doi: 10.1111/1751-2980.13103
|
| 3 |
Christa Buechler, Charalampos Aslanidis. Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(5): 158658 doi: 10.1016/j.bbalip.2020.158658
|
| 4 |
Tawfik Khoury, Amir Mari, Hana Amara, Mohamed Jabaren, Abdulla Watad, Wiliam Nseir, Wisam Sbeit, Mahmud Mahamid. Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/6415757
|
| 5 |
Chalermrat Bunchorntavakul, K. Rajender Reddy. Pharmacologic Management of Portal Hypertension. Clinics in Liver Disease 2019; 23(4): 713 doi: 10.1016/j.cld.2019.06.004
|
| 6 |
Niki Katsiki, Vasilios G Athyros. Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment. Current Medical Research and Opinion 2019; 35(7): 1305 doi: 10.1080/03007995.2019.1589152
|
| 7 |
H. A. Elmekawy, F. Belal, A. E. Abdelaziz, K. S. Abdelkawy, A. A. Ali, F. Elbarbry. Pharmacokinetic interaction between atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteers. European Journal of Clinical Pharmacology 2021; 77(9): 1369 doi: 10.1007/s00228-021-03130-z
|
| 8 |
Xin Ding, Xu He, Bulang Tang, Tian Lan. Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies. Chinese Medicine 2024; 19(1) doi: 10.1186/s13020-024-00894-1
|
| 9 |
V. Ye. Molodtsov, O. I. Fediv, G. Ya. Stupnytska. ЕФЕКТИВНІСТЬ ЗАСТОСУВАННЯ АТОРВАСТАТИНУ ПРИ ПОЄДНАННІ АЛКОГОЛЬНОЇ ХВОРОБИ ПЕЧІНКИ ТА АРТЕРІАЛЬНОЇ ГІПЕРТЕНЗІЇ. Здобутки клінічної і експериментальної медицини 2020; (2): 126 doi: 10.11603/1811-2471.2020.v.i2.11188
|
| 10 |
Abdolkhaleg Deezagi, Naser Safari. Rosuvastatin inhibit spheroid formation and epithelial–mesenchymal transition (EMT) in prostate cancer PC-3 cell line. Molecular Biology Reports 2020; 47(11): 8727 doi: 10.1007/s11033-020-05918-1
|
| 11 |
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
|
| 12 |
Peter Jarcuska, Ahmed Abdel-Razik, Robert Flisiak, Ram B. Singh. Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular Risk. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/7369314
|
| 13 |
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2022; 10(2): 339 doi: 10.14218/JCTH.2021.00268
|
| 14 |
Narendra S. Choudhary, Sanjiv Saigal, Neeraj Saraf, Arvinder S. Soin. Acute Onset Significant Muscle Weakness in a Patient Awaiting Liver Transplantation: Look for Statins. Journal of Clinical and Experimental Hepatology 2017; 7(1): 66 doi: 10.1016/j.jceh.2016.09.007
|
| 15 |
Ruirui Feng, Xiaozhong Guo, Yun Kou, Xiangbo Xu, Cen Hong, Wenwen Zhang, Yang An, Cyriac Abby Philips, Andrea Mancuso, Xingshun Qi. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis. Postgraduate Medicine 2021; 133(6): 626 doi: 10.1080/00325481.2021.1930560
|
| 16 |
Pamela Tietz-Bogert, Minsuk Kim, Angela Cheung, James Tabibian, Julie Heimbach, Charles Rosen, Madhumitha Nandakumar, Konstantinos Lazaridis, Nicholas LaRusso, Jaeyun Sung, Steven O’Hara. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis. International Journal of Molecular Sciences 2018; 19(10): 3188 doi: 10.3390/ijms19103188
|
| 17 |
Haiyan Zhou, Maeda Toshiyoshi,, Wenli Zhao, Ye Zhao, Yan Zhao. Statins on nonalcoholic fatty liver disease: A systematic review and meta-analysis of 14 RCTs. Medicine 2023; 102(26): e33981 doi: 10.1097/MD.0000000000033981
|
| 18 |
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, Alberto Mondelli, Serena Bursi, Giovanna Onfiani, Francesca Carubbi, Amedeo Lonardo. Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes. Atherosclerosis 2019; 284: 66 doi: 10.1016/j.atherosclerosis.2019.02.028
|
| 19 |
Stuart McPherson, Shion Gosrani, Sarah Hogg, Preya Patel, Aaron Wetten, Rachael Welton, Kate Hallsworth, Matthew Campbell. Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis C. BMJ Open Gastroenterology 2020; 7(1): e000470 doi: 10.1136/bmjgast-2020-000470
|
| 20 |
Hui Li. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma. Digestive and Liver Disease 2022; 54(5): 598 doi: 10.1016/j.dld.2021.07.006
|
| 21 |
Urša Kovač, Cene Skubic, Laura Bohinc, Damjana Rozman, Tadeja Režen. Oxysterols and Gastrointestinal Cancers Around the Clock. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00483
|
| 22 |
Anne Noom, Birgit Sawitzki, Petra Knaus, Georg N. Duda. A two-way street – cellular metabolism and myofibroblast contraction. npj Regenerative Medicine 2024; 9(1) doi: 10.1038/s41536-024-00359-x
|
| 23 |
Yi-Hao Yen, Kwong-Ming Kee, Chien-Hung Chen, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Tatsuo Kanda. Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C. PLOS ONE 2019; 14(1): e0208858 doi: 10.1371/journal.pone.0208858
|
| 24 |
Francisco J. Zapatero-Belinchón, Rina Ötjengerdes, Julie Sheldon, Benjamin Schulte, Belén Carriquí-Madroñal, Graham Brogden, Laura M. Arroyo-Fernández, Florian W. R. Vondran, Benjamin Maasoumy, Thomas von Hahn, Gisa Gerold. Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity. Cells 2021; 10(7): 1626 doi: 10.3390/cells10071626
|
| 25 |
Yue Chang, Qinyu Liu, Zidong Zhou, Yuping Ding, Mei Yang, Wei Xu, Kai Chen, Qing Zhang, Zhenguo Wang, Hai Li. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis. Technology in Cancer Research & Treatment 2020; 19: 153303382093488 doi: 10.1177/1533033820934881
|
| 26 |
Myung Ji Goh, Dong Hyun Sinn. Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?. Clinical and Molecular Hepatology 2022; 28(3): 380 doi: 10.3350/cmh.2021.0366
|
| 27 |
Yi-Hsuan Wei, Shu-Lang Liao, Sen-Hsu Wang, Chia-Chun Wang, Chang-Hao Yang. Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves’ Ophthalmopathy-Derived Orbital Fibroblasts via RhoA-Mediated ERK and p38 Signaling Pathways. Frontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.607968
|
| 28 |
Elias Khajeh, Arash Dooghaie Moghadam, Pegah Eslami, Sadeq Ali-Hasan-Al-Saegh, Ali Ramouz, Saeed Shafiei, Omid Ghamarnejad, Sepehr Abbasi Dezfouli, Christian Rupp, Christoph Springfeld, Carlos Carvalho, Pascal Probst, Seyed Mostafa Mousavizadeh, Arianeb Mehrabi. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09192-1
|
| 29 |
Christopher Kasia, Steven J. Scaglione. Patients With Chronic Liver Disease/Cirrhosis Should Not Take Statin Medications. Clinical Liver Disease 2019; 13(4): 106 doi: 10.1002/cld.788
|
| 30 |
Dominik Safcak, Sylvia Drazilova, Jakub Gazda, Igor Andrasina, Svetlana Adamcova-Selcanova, Radovan Barila, Michal Mego, Marek Rac, Lubomir Skladany, Miroslav Zigrai, Martin Janicko, Peter Jarcuska. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Clinical Patterns, Outcomes, and Prognostic Factors for Overall Survival—A Retrospective Analysis of a Slovak Cohort. Journal of Clinical Medicine 2021; 10(14): 3186 doi: 10.3390/jcm10143186
|
| 31 |
Sneha Kothari, Hiteshi Dhami-Shah, Samir R. Shah. Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2019; 9(6): 723 doi: 10.1016/j.jceh.2019.06.003
|
| 32 |
Sura Salman Ejam, Raed Obaid Saleh, Maria Jade Catalan Opulencia, Mazin AA Najm, Aziza Makhmudova, Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Moaed E Al-Gazally, Ali Thaeer Hammid, Yasser Fakri Mustafa, Sergushina Elena Sergeevna, Sajad Karampoor, Rasoul Mirzaei. Pathogenic role of 25-hydroxycholesterol in cancer development and progression. Future Oncology 2022; 18(39): 4415 doi: 10.2217/fon-2022-0819
|
| 33 |
Antonio Magan-Fernandez, Manfredi Rizzo, Giuseppe Montalto, Giulio Marchesini. Statins in liver disease: not only prevention of cardiovascular events. Expert Review of Gastroenterology & Hepatology 2018; 12(8): 743 doi: 10.1080/17474124.2018.1477588
|
| 34 |
Daniela M. Santos, Lorena Pantano, Gina Pronzati, Paula Grasberger, Clemens K. Probst, Katharine E. Black, Jillian J. Spinney, Lida P. Hariri, Royale Nichols, Yufei Lin, Michael Bieler, Peter Seither, Paul Nicklin, David Wyatt, Andrew M. Tager, Benjamin D. Medoff. Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis. American Journal of Respiratory Cell and Molecular Biology 2020; 62(4): 479 doi: 10.1165/rcmb.2019-0296OC
|
| 35 |
Armita M. Gorabi, Nasim Kiaie, Vanessa Bianconi, Tannaz Jamialahmadi, Khalid Al-Rasadi, Thomas P. Johnston, Matteo Pirro, Amirhossein Sahebkar. Antiviral effects of statins. Progress in Lipid Research 2020; 79: 101054 doi: 10.1016/j.plipres.2020.101054
|
| 36 |
Mazaher Ahmadi, Shayan Amiri, Stevan Pecic, Filip Machaj, Jakub Rosik, Marek J. Łos, Javad Alizadeh, Reza Mahdian, Simone C. da Silva Rosa, Dedmer Schaafsma, Shahla Shojaei, Tayyebeh Madrakian, Amir A. Zeki, Saeid Ghavami. Pleiotropic effects of statins: A focus on cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(12): 165968 doi: 10.1016/j.bbadis.2020.165968
|
| 37 |
Mudassar Aleem, Alina Zainab, Azfar Hameed, Abdul Basit Khan, Syed Zahid Ali, Shifa Younus. Comparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With Dyslipidemia. Cureus 2022; doi: 10.7759/cureus.22595
|
| 38 |
K.S. Abdelkawy, Fathalla Belal, AbdelazizE Abdelaziz, H. A. Elmekawy, M. Y. Abdelgaied, N. M. El-Khodary. Statins Increase the Bioavailability of Fixed-Dose Combination of Sofosbuvir/Ledipasvir by Inhibition of P-glycoprotein. Drug Research 2022; 72(06): 319 doi: 10.1055/a-1835-1690
|
| 39 |
SK Jha, K Saharawat, R Keshari, P Jha, S Purkayastha, R Ranjan. Addition of Simvastatin to Carvedilol and Endoscopic Variceal Ligation improves rebleeding and survival in patients with Child-Pugh A and B class but not in Child Pugh C class. Annals of Clinical Gastroenterology and Hepatology 2019; 3(1): 020 doi: 10.29328/journal.acgh.1001010
|